Nicholas W. Baxter's Insider Trades & SAST Disclosures
Nicholas W. Baxter's most recent trade in Lexaria Bioscience Corp was a trade of 12,000 Stock Options done . Disclosure was reported to the exchange on July 26, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nicholas W. Baxter.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp | Nicholas W. Baxter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 12,000 | 52,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Nicholas W. Baxter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 5,000 | 40,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Nicholas W. Baxter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 5,000 | 35,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Nicholas W. Baxter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 18,200 | 30,000 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Nicholas W. Baxter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 3,400 | 11,800 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Nicholas W. Baxter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,900 | 8,400 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Nicholas W. Baxter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 5,000 | 6,500 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Nicholas W. Baxter | Director | Other type of transaction at price $ 0.00 per share. | 07 May 2021 | 5,000 | 1,500 | - | - | Stock Options | |
| Lexaria Bioscience Corp | Nicholas W. Baxter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2021 | 1,500 | 6,500 | - | - | Stock Options |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges